Skip to main content
Top
Published in: Supportive Care in Cancer 1/2016

01-01-2016 | Original Article

Relationship between palliative care consultation service and end-of-life outcomes

Authors: Li-Fen Wu, Chi-Ming Chu, Yu-Guang Chen, Ching-Liang Ho, Hsueh-Hsing Pan

Published in: Supportive Care in Cancer | Issue 1/2016

Login to get access

Abstract

Purpose

Palliative care consultation service (PCCS) is currently utilized to provide care to terminal patients in Taiwan. However, there is little research on the relationship between PCCS and end-of-life outcomes. This study aimed to elucidate the association between PCCS and end-of-life outcomes in terminal cancer patients.

Methods

Retrospective chart reviews of terminal cancer patients who consulted the PCCS of a medical center in Taiwan from January 2007 to December 2012 were performed. Data on 1369 patients were recorded, which included details of outcomes such as discharge from hospital, transfer to hospice ward, and death after PCCS termination. Other variables such as demographics, disease-related information, symptoms, and psychosocial needs were also evaluated. Logistic regression models were employed to estimate the adjusted odds ratios and related 95 % confidence intervals.

Results

The Eastern Cooperative Oncology Group performance status, timing of do-not-resuscitate (DNR) signature, constipation, and spiritual problems experienced by the patients were important predictors for terminal cancer patients who were discharged from the hospital or had expired at the time of PCCS termination. Age, gender, primary cancer diagnosis, timing of DNR signature, constipation, and other physical symptoms were the key predictors for patients who were transferred to the hospice ward or had expired.

Conclusions

This study confirms the outcomes of PCCS and highlights the important predictors for patients at PCCS termination. These factors can be targeted to improve and enhance the quality of PCCS rendered in the future.
Literature
2.
go back to reference World Health Organization (2002) National cancer control programmes: policies and managerial guidelines, 2nd edn. World Health Organization, Geneva World Health Organization (2002) National cancer control programmes: policies and managerial guidelines, 2nd edn. World Health Organization, Geneva
3.
go back to reference Engeser P, Hermann K, Szecsenyi J, Peters-Klimm F (2014) Symptom control and place of death in palliative cancer patients in primary care: results of the controlled PAMINO evaluation study. Schmerz 28(6):607–613. doi:10.1007/s00482-014-1464-9 CrossRefPubMed Engeser P, Hermann K, Szecsenyi J, Peters-Klimm F (2014) Symptom control and place of death in palliative cancer patients in primary care: results of the controlled PAMINO evaluation study. Schmerz 28(6):607–613. doi:10.​1007/​s00482-014-1464-9 CrossRefPubMed
4.
go back to reference Edwin AK, McGee SJ, Opare-Lokko EA, Gyakobo MK (2014) A structured approach to end-of-life decision making improves quality of care for patients with terminal illness in a teaching hospital in Ghana. Am J Hosp Palliat Care. doi: 10.1177/1049909114557350 Edwin AK, McGee SJ, Opare-Lokko EA, Gyakobo MK (2014) A structured approach to end-of-life decision making improves quality of care for patients with terminal illness in a teaching hospital in Ghana. Am J Hosp Palliat Care. doi: 10.​1177/​1049909114557350​
5.
go back to reference van der Eerden M, Csikos A, Busa C, Hughes S, Radbruch L, Menten J, Hasselaar J, Groot M (2014) Experiences of patients, family and professional caregivers with integrated palliative care in Europe: protocol for an international, multicenter, prospective, mixed method study. BMC Palliat Care 13(1):52. doi:10.1186/1472-684x-13-52 PubMedCentralCrossRefPubMed van der Eerden M, Csikos A, Busa C, Hughes S, Radbruch L, Menten J, Hasselaar J, Groot M (2014) Experiences of patients, family and professional caregivers with integrated palliative care in Europe: protocol for an international, multicenter, prospective, mixed method study. BMC Palliat Care 13(1):52. doi:10.​1186/​1472-684x-13-52 PubMedCentralCrossRefPubMed
7.
go back to reference Chou WC, Hung YS, Kao CY, Su PJ, Hsieh CH, Chen JS, Liau CT, Lin YC, Liaw CC, Wang HM (2013) Impact of palliative care consultative service on disease awareness for patients with terminal cancer. Support Care Cancer 21(7):1973–1981. doi:10.1007/s00520-013-1733-7 CrossRefPubMed Chou WC, Hung YS, Kao CY, Su PJ, Hsieh CH, Chen JS, Liau CT, Lin YC, Liaw CC, Wang HM (2013) Impact of palliative care consultative service on disease awareness for patients with terminal cancer. Support Care Cancer 21(7):1973–1981. doi:10.​1007/​s00520-013-1733-7 CrossRefPubMed
8.
12.
go back to reference Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655CrossRefPubMed Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655CrossRefPubMed
14.
go back to reference Kao CY, Wang HM, Tang SC, Huang KG, Jaing TH, Liu CY, Liu KH, Shen WC, Wu JH, Hung YS, Hsu HC, Chen JS, Liau CT, Lin YC, Su PJ, Hsieh CH, Chou WC (2014) Predictive factors for do-not-resuscitate designation among terminally ill cancer patients receiving care from a palliative care consultation service. J Pain Symptom Manag 47:271–282. doi:10.1016/j.jpainsymman.2013.03.020 CrossRef Kao CY, Wang HM, Tang SC, Huang KG, Jaing TH, Liu CY, Liu KH, Shen WC, Wu JH, Hung YS, Hsu HC, Chen JS, Liau CT, Lin YC, Su PJ, Hsieh CH, Chou WC (2014) Predictive factors for do-not-resuscitate designation among terminally ill cancer patients receiving care from a palliative care consultation service. J Pain Symptom Manag 47:271–282. doi:10.​1016/​j.​jpainsymman.​2013.​03.​020 CrossRef
15.
go back to reference Cheng SY, Dy S, Hu WY, Chen CY, Chiu TY (2012) Factors affecting the improvement of quality of dying of terminally ill patients with cancer through palliative care: a ten-year experience. J Palliat Med 15(8):854–862. doi:10.1089/jpm.2012.0033 CrossRefPubMed Cheng SY, Dy S, Hu WY, Chen CY, Chiu TY (2012) Factors affecting the improvement of quality of dying of terminally ill patients with cancer through palliative care: a ten-year experience. J Palliat Med 15(8):854–862. doi:10.​1089/​jpm.​2012.​0033 CrossRefPubMed
17.
go back to reference Lal M, Raheja S, Kale S, Das N, Gogia AR, Bhowmik KT (2012) An experience with 156 patients attending a newly organized pain and palliative care clinic in a tertiary hospital. Indian J Cancer 49:293–297CrossRefPubMed Lal M, Raheja S, Kale S, Das N, Gogia AR, Bhowmik KT (2012) An experience with 156 patients attending a newly organized pain and palliative care clinic in a tertiary hospital. Indian J Cancer 49:293–297CrossRefPubMed
18.
go back to reference Miyashita M, Arai K, Yamada Y, Owada M, Sasahara T, Kawa M, Mukaiyama T (2009) Discharge from a palliative care unit: prevalence and related factors from a retrospective study in Japan. J Palliat Med 12:142–149. doi:10.1089/jpm.2008.0216 CrossRefPubMed Miyashita M, Arai K, Yamada Y, Owada M, Sasahara T, Kawa M, Mukaiyama T (2009) Discharge from a palliative care unit: prevalence and related factors from a retrospective study in Japan. J Palliat Med 12:142–149. doi:10.​1089/​jpm.​2008.​0216 CrossRefPubMed
Metadata
Title
Relationship between palliative care consultation service and end-of-life outcomes
Authors
Li-Fen Wu
Chi-Ming Chu
Yu-Guang Chen
Ching-Liang Ho
Hsueh-Hsing Pan
Publication date
01-01-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2741-6

Other articles of this Issue 1/2016

Supportive Care in Cancer 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine